LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy Patients | Business Wire

LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy Patients | Business Wire: LivaNova PLC announced first implant and official launch of the Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with VNS Therapy.